Zura Bio Limited Class A Ordinary Shares (NASDAQ:ZURA) — Stock Price
Zura Bio Limited Class A Ordinary Shares (NASDAQ:ZURA) is currently trading at $5.63 USD, down 5.62% today. Over the past 52 weeks, shares have ranged between $1.47 and $7.04. This page tracks Zura Bio Limited Class A Ordinary Shares's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Zura Bio Limited Class A Ordinary Shares market cap and net worth.
Zura Bio Limited Class A Ordinary Shares (ZURA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Zura Bio Limited Class A Ordinary Shares's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Zura Bio Limited Class A Ordinary Shares Income Statement — Revenue, Profit & Earnings by Year
Zura Bio Limited Class A Ordinary Shares's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Revenue | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $9.00K | — | — |
| Gross Profit | $-9.00K | — | — |
| Research & Development | $24.40 Million | $44.00 Million | $23.69 Million |
| SG&A | $30.79 Million | $18.64 Million | $3.47 Million |
| Total Operating Expenses | $55.19 Million | $62.64 Million | $27.16 Million |
| Operating Income | $-55.19 Million | $-62.64 Million | $-27.16 Million |
| EBITDA | $-55.18 Million | $-62.64 Million | $-27.16 Million |
| EBIT | $-55.19 Million | $-60.56 Million | $-27.33 Million |
| Interest Expense | — | — | — |
| Income Before Tax | $-52.40 Million | $-60.56 Million | $-27.33 Million |
| Income Tax Expense | $-7.02 Million | $-203.00K | $-570.00 |
| Net Income | $-52.40 Million | $-60.36 Million | $-25.74 Million |
Zura Bio Limited Class A Ordinary Shares Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Zura Bio Limited Class A Ordinary Shares's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Assets | $179.53 Million | $100.84 Million | $5.26 Million | $140.55 Million |
| Total Current Assets | $178.74 Million | $100.84 Million | $1.78 Million | $1.15 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | — | — | — | — |
| Total Liabilities | $19.51 Million | $21.29 Million | $27.32 Million | $10.35 Million |
| Total Current Liabilities | $19.51 Million | $20.30 Million | $14.82 Million | $272.29K |
| Long-term Debt | — | — | — | — |
| Net Debt | $-176.50 Million | $-99.81 Million | $6.19 Million | $-729.22K |
| Total Stockholder Equity | $146.81 Million | $59.33 Million | $-32.06 Million | $130.20 Million |
| Retained Earnings | $-155.90 Million | $-103.49 Million | $-32.06 Million | $-9.18 Million |
Zura Bio Limited Class A Ordinary Shares Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Zura Bio Limited Class A Ordinary Shares generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | $-28.08 Million | $-15.05 Million | $-1.20 Million | $-1.10 Million |
| Capital Expenditures | $75.00K | $8.00 Million | $12.00 Million | $4.00 |
| Free Cash Flow | $-28.15 Million | $-23.05 Million | $-13.20 Million | $-1.10 Million |
| Investing Cash Flow | $-5.08 Million | $-8.00 Million | $-12.00 Million | $-139.38 Million |
| Financing Cash Flow | $109.84 Million | $121.29 Million | $14.77 Million | $141.21 Million |
| Dividends Paid | — | — | — | — |
| Stock-Based Compensation | $16.80 Million | $9.65 Million | $334.00K | — |
| Depreciation | $9.00K | $0.00 | — | — |
| Change in Cash | $76.69 Million | $98.24 Million | $1.57 Million | $729.22K |
Zura Bio Limited Class A Ordinary Shares Earnings History — EPS Actual vs. Analyst Estimates
Track Zura Bio Limited Class A Ordinary Shares's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Nov 13, 2025 | -0.17 | -0.31 | +45.16% |
| Aug 14, 2025 | -0.17 | -0.30 | +43.33% |
| May 08, 2025 | -0.19 | -0.29 | +34.48% |
| Mar 25, 2025 | -0.10 | -0.24 | +58.33% |
| Nov 07, 2024 | -0.26 | -0.13 | -100.00% |
| Aug 13, 2024 | -0.17 | -0.15 | -13.33% |
| May 09, 2024 | -0.02 | -0.23 | +91.30% |
| Mar 28, 2024 | -0.19 | -0.23 | +17.39% |